BETi-211
BETi-211 is an orally active BET inhibitor (Ki: 50 [1].
Product Specifications
CAS Number
[1995867-02-1]
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/beti-211.html
Smiles
COCC1=NC(NC2=CC(C3CC3)=NN2CC)=C4C(NC5=C4C=C(OC)C(C6=C(C)ON=C6C)=C5)=N1
Molecular Formula
C26H29N7O3
Molecular Weight
487.55
References & Citations
[1]Bai L, et al. Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer. Cancer Res. 2017 May 1;77 (9) :2476-2487.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15182507 1 Vial
Lentiviral mouse Atat1 shRNA (UAS) - Lentiviral mouse Atat1 shRNA (UAS, RFP) (25)
Ask
View Details 
GTR15150722 1 Vial
Lentiviral human ASB4 shRNA (UAS) - Lentiviral human ASB4 shRNA (UAS, iRFP) (25)
Ask
View Details